Imerzoukene F - Search Results

1

Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation.

Noble J, Metzger A, Naciri Bennani H, Daligault M, Masson D, Terrec F, Imerzoukene F, Bardy B, Fiard G, Marlu R, Chevallier E, Janbon B, Malvezzi P, Rostaing L, Jouve T. Noble J, et al. Among authors: imerzoukene f. J Clin Med. 2021 Mar 23;10(6):1316. doi: 10.3390/jcm10061316. J Clin Med. 2021. PMID: 33806743 Free PMC article.

2

Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.

Jouve T, Marlu R, Naciri Bennani H, Noble J, Chevallier E, Motte L, Imerzoukene F, Malvezzi P, Rostaing L. Jouve T, et al. Among authors: imerzoukene f. J Clin Apher. 2021 Aug;36(4):574-583. doi: 10.1002/jca.21895. Epub 2021 Mar 30. J Clin Apher. 2021. PMID: 33783856

3

Treatment of antibody-mediated rejection with double-filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation.

Naciri Bennani H, Daligault M, Noble J, Bardy B, Motte L, Giovannini D, Emprou C, Fiard G, Imerzoukene F, Bourdin A, Masson D, Janbon B, Malvezzi P, Rostaing L, Jouve T. Naciri Bennani H, et al. Among authors: imerzoukene f. J Clin Apher. 2021 Aug;36(4):584-594. doi: 10.1002/jca.21897. Epub 2021 Mar 30. J Clin Apher. 2021. PMID: 33783868

4

Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.

Naciri Bennani H, Bonzi JY, Noble J, Terrec F, Motte L, Imerzoukene F, Bugnazet M, Giovannini D, Janbon B, Malvezzi P, Rostaing L, Jouve T. Naciri Bennani H, et al. Among authors: imerzoukene f. Blood Purif. 2020;49(3):322-333. doi: 10.1159/000504244. Epub 2020 Jan 7. Blood Purif. 2020. PMID: 31913143

5

Effect of immunoadsorption alone or combined with membrane filtration on hemostasis parameters.

Marlu R, Bennani HN, Seyve L, Malvezzi P, Janbon B, Noble J, Christophe M, Motte L, Imerzoukene F, Chevallier E, Rostaing L, Jouve T. Marlu R, et al. Among authors: imerzoukene f. J Clin Apher. 2020 Sep;35(5):444-452. doi: 10.1002/jca.21825. Epub 2020 Aug 17. J Clin Apher. 2020. PMID: 32805070

6

Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center.

Naciri Bennani H, Noble J, Chevallier E, Terrec F, Motte L, Giroux-Lathuile C, Bugnazet M, Imerzoukene F, Janbon B, Malvezzi P, Rostaing L, Jouve T. Naciri Bennani H, et al. Among authors: imerzoukene f. J Clin Apher. 2021 Feb;36(1):149-160. doi: 10.1002/jca.21857. Epub 2020 Nov 23. J Clin Apher. 2021. PMID: 33230824

7

Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single-membrane filtration, and double-filtration plasmapheresis.

Marlu R, Naciri Bennani H, Seyve L, Noble J, Chevallier E, Motte L, Imerzoukene F, Bugnazet M, Christophe M, Malvezzi P, Jouve T, Rostaing L. Marlu R, et al. Among authors: imerzoukene f. J Clin Apher. 2021 Jun;36(3):408-419. doi: 10.1002/jca.21879. Epub 2021 Jan 28. J Clin Apher. 2021. PMID: 33506958

8

Early Steroid Withdrawal After Kidney Transplantation in Patients at Risk for New-Onset Diabetes After Transplantation.

Gierczak V, Noble J, Malvezzi P, Janbon B, Terrec F, Chevallier E, Naciri Bennani H, Bugnazet M, Imerzoukene F, Rostaing L, Jouve T. Gierczak V, et al. Among authors: imerzoukene f. Transplant Proc. 2021 Sep;53(7):2216-2226. doi: 10.1016/j.transproceed.2021.07.047. Epub 2021 Aug 26. Transplant Proc. 2021. PMID: 34454728

9

Tocilizumab in the Treatment of Chronic Antibody-Mediated Rejection Post Kidney Transplantation: Clinical and Histological Monitoring.

Noble J, Giovannini D, Laamech R, Imerzoukene F, Janbon B, Marchesi L, Malvezzi P, Jouve T, Rostaing L. Noble J, et al. Among authors: imerzoukene f. Front Med (Lausanne). 2021 Dec 24;8:790547. doi: 10.3389/fmed.2021.790547. eCollection 2021. Front Med (Lausanne). 2021. PMID: 35004757 Free PMC article.

10

Cytomegalovirus disease in de novo kidney-transplant recipients: comparison of everolimus-based immunosuppression without prophylaxis with mycophenolic acid-based immunosuppression with prophylaxis.

Manière L, Noble J, Terrec F, Bennani HN, Chevallier E, Janbon B, Germi R, Bugnazet M, Imerzoukene F, Malvezzi P, Rostaing L, Jouve T. Manière L, et al. Among authors: imerzoukene f. Int Urol Nephrol. 2021 Mar;53(3):591-600. doi: 10.1007/s11255-020-02676-8. Epub 2020 Oct 15. Int Urol Nephrol. 2021. PMID: 33058036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page